• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of Anti-TNFα Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.

作者信息

Tursi Antonio, Papa Alfredo

机构信息

Territorial Gastroenterology Service, ASL BAT, Andria (BT), Italy.

Division of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.

出版信息

J Crohns Colitis. 2020 Nov 7;14(11):1646-1647. doi: 10.1093/ecco-jcc/jjaa076.

DOI:10.1093/ecco-jcc/jjaa076
PMID:32303756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7188162/
Abstract
摘要

相似文献

1
Impact of Anti-TNFα Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.抗TNFα抗体对炎症性肠病患者感染新冠病毒的风险及其严重程度的影响。
J Crohns Colitis. 2020 Nov 7;14(11):1646-1647. doi: 10.1093/ecco-jcc/jjaa076.
2
SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?严重儿童克罗恩病中的新型冠状病毒2型感染。抗肿瘤坏死因子α治疗情况如何？
Dig Liver Dis. 2020 Nov;52(11):1244-1245. doi: 10.1016/j.dld.2020.06.047. Epub 2020 Jul 11.
3
The Many Faces of COVID-19: Atypical Presentation of COVID-19 in a Patient With Crohn's Disease With Acute Diarrhea Leading to Severe Hypovolemic Hyponatremia-A Case Report.新冠病毒病的多样表现：1例克罗恩病患者新冠病毒病的非典型表现伴急性腹泻导致严重低血容量性低钠血症——病例报告
Am J Gastroenterol. 2020 Oct;115(10):1730-1731. doi: 10.14309/ajg.0000000000000814.
4
First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient.免疫功能低下患者中首例与SARS-CoV-2骨髓浸润相关的持续性全血细胞减少病例。
Ann Oncol. 2020 Oct;31(10):1418-1419. doi: 10.1016/j.annonc.2020.06.016. Epub 2020 Jun 29.
5
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体多次检测不到的新型冠状病毒肺炎（COVID-19）患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
6
Successful use of methylprednisolone for treating severe COVID-19.甲基泼尼松龙成功用于治疗重症新型冠状病毒肺炎。
J Allergy Clin Immunol. 2020 Aug;146(2):325-327. doi: 10.1016/j.jaci.2020.05.021. Epub 2020 May 29.
7
Severe, Symptomatic Reinfection in a Patient with COVID-19.一名新冠肺炎患者发生严重的有症状再感染
R I Med J (2013). 2020 Nov 9;103(10):24-26.
8
Will COVID-19 Infection be Less Severe in Ulcerative Colitis Than in Crohn's Patients, Due to a Lower Rate of Smokers?由于溃疡性结肠炎患者中吸烟者的比例较低，COVID-19感染在溃疡性结肠炎患者中的严重程度是否会低于克罗恩病患者？
J Crohns Colitis. 2020 Nov 7;14(11):1648. doi: 10.1093/ecco-jcc/jjaa077.
9
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者：体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
10
Immune status could be associated with severity in COVID-19 patients.免疫状态可能与新冠肺炎患者的病情严重程度相关。
Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):13-16. doi: 10.1590/1806-9282.66.S2.13. eCollection 2020.

引用本文的文献

1
Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges.探讨克罗恩病中与 SARS-CoV-2 相关免疫病理学：从分子机制到治疗挑战。
Virol J. 2024 Nov 13;21(1):288. doi: 10.1186/s12985-024-02529-1.
2
Inflammatory Bowel Disease during COVID-19 Pandemic: A Prospective Cohort Study of Incidence Rate and Patients' Concerns.新冠疫情期间的炎症性肠病：发病率及患者担忧的前瞻性队列研究
Middle East J Dig Dis. 2022 Jan;14(1):24-33. doi: 10.34172/mejdd.2022.252. Epub 2022 Jan 30.
3
Influence of biologic and conventional disease-modifying antirheumatic drugs on COVID-19 incidence among rheumatic patients during the first and second wave of the pandemic in Iran.在伊朗大流行的第一波和第二波期间，生物制剂和传统改善病情抗风湿药物对风湿病患者中新冠病毒感染发病率的影响。
Reumatologia. 2022;60(4):231-241. doi: 10.5114/reum.2022.119039. Epub 2022 Sep 7.
4
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment.跨膜丝氨酸蛋白酶 2 和血管紧张素转换酶 2 抗炎受体治疗 COVID-19/炎症性肠病。
World J Gastroenterol. 2021 Dec 14;27(46):7943-7955. doi: 10.3748/wjg.v27.i46.7943.
5
A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol.COVID-19疫情期间炎症性肠病患者管理支持系统：伊朗经验——研究方案
Middle East J Dig Dis. 2020 Oct;12(4):238-245. doi: 10.34172/mejdd.2020.188.
6
Clinical and Pathogenic Correlations Between SARS-CoV-2 Infection and Hemolytic Uremic Syndrome in Children.儿童新型冠状病毒感染与溶血尿毒综合征之间的临床与病原学关联
Maedica (Bucur). 2020 Sep;15(3):376-380. doi: 10.26574/maedica.2020.15.3.376.